Clinical trial

Dolutegravir Pediatric Liquid Formulation Study

NCT03921723

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-05-07

PhasePHASE1

Study timeline

Study start (actual)2019-05-07Date precision: day

Registry last updated2020-07-31

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

Dolutegravir dispersible tabletDRUG

Dolutegravir oral suspensionDRUG

Dolutegravir oral solutionDRUG

Sponsors & collaborators

ViiV Healthcarelead sponsor

Mapped research locations

NottinghamUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03921723 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.